Press releases & statements | Novavax Investor Relations
WEBNovavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine. We are a biotechnology company committed to addressing serious infectious diseases globally through the discovery and development of innovative vaccines.
Press Center - Novavax
WEBAug 30, 2024 · Stay current with Novavax news as we make progress in discovering and developing innovative vaccines to help protect against serious infectious diseases.
Novavax 2024-2025 Formula COVID-19 Vaccine Available at …
WEBAug 30, 2024 · Doses of Novavax's 2024-2025 Formula COVID-19 vaccine now available at thousands of locations nationwide Novavax's updated vaccine is the only protein-based option available ... We caution investors not to place considerable reliance on forward-looking statements contained in this press release. You …
FDA Authorizes Updated Novavax COVID-19 Vaccine to Better …
WEBAug 30, 2024 · For Immediate Release: August 30, 2024. Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more...
Novavax 2023-2024 COVID-19 Vaccine Now Authorized and …
WEBSep 12, 2023 · This Emergency Use Authorization and CDC recommendation makes Novavax's vaccine the only protein-based non-mRNA COVID vaccine option in the U.S. Novavax expects doses will be available in thousands of locations across the U.S. in the coming days, including CVS Pharmacy and Rite Aid.
Novavax Submits Application to U.S. FDA for Updated Protein …
WEBJun 14, 2024 · Novavax intends to have its vaccine in pre-filled syringes available in the U.S. for immediate release post-authorization and following recommendation by the U.S. CDC
Novavax 2023-2024 COVID-19 Vaccine Now Authorized and ... - Nasdaq
WEBPublished. Oct 3, 2023 3:50pm EDT. This Emergency Use Authorization and CDC recommendation makes Novavax's vaccine the only protein-based non-mRNA COVID vaccine option in the U.S. Novavax...
Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four …
WEBGAITHERSBURG, Md., Aug. 5, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced...
Novavax Continues Progress Towards Delivery of its Protein …
WEBSeptember 11, 2023. · Doses of the updated protein-based non-MRNA Novavax COVID-19 Vaccine, Adjuvanted (Formula 2023-2024) arrived in the U.S. today and are ready to distribute for the fall vaccination campaign, pending FDA and CDC action.
Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized …
WEBAug 30, 2024 · VACCINE AUTHORIZATION (U.S.) Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) is indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute...
- Some results have been removed